Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 758 of 5804
-
New drug shows promise for rare fat disorder
Disease control CompletedThe primary objectives of the study are to estimate the effects of REGN4461 on glycemic parameters in the subset of patients with elevated baseline hemoglobin A1c levels (HbA1c ≥7%) and to estimate the effects of REGN4461 on fasting triglyceride levels in the subset of patients w…
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for hard-to-treat lung cancer: experimental drug targets MET gene
Disease control Recruiting nowThis study will evaluate REGN5093 for the treatment of Non-Small Cell Lung Cancer (NSCLC) with MET alteration. The main purpose of this study is to determine the safety, tolerability, and effectiveness of REGN5093. The study has two phases. The main goal of Phase 1 is to determi…
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug tavapadon tested to ease Parkinson's symptoms
Disease control CompletedThe purpose of this study is to assess the efficacy, safety, tolerability and pharmacokinetics (PK) of flexible doses of tavapadon in participants with Parkinson's Disease.
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug combo shows promise for aggressive lymphoma patients
Disease control CompletedThis is a prospective single-arm, multi-center, phase II clinical trial to observe the efficacy and safety of R-CHOP (Rituximab-Cyclophosphamide, Epirubicin, Vincristine and Prednisone) combined with lenalidomide in the first-line treatment for patients with medium to high risk/h…
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New gene therapy targets Parkinson's in patients with specific gene flaw
Disease control OngoingStudy J3Z-MC-OJAA is a Phase 1/2a, multicenter, open-label, ascending dose, first in-human study that will evaluate the safety of intracisternal LY3884961 administration in patients with moderate to severe Parkinson's disease with at least 1 pathogenic GBA1 mutation. Two dose lev…
Phase: PHASE1, PHASE2 • Sponsor: Prevail Therapeutics • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New drug duo shows promise against tough uterine cancer
Disease control OngoingThis research study is studying a drug combination as a possible treatment for endometrial cancer. The drugs involved in this study are: * mirvetuximab soravtansine (IMGN853) * pembrolizumab
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Parkinson's fall risk could be cut in half by common memory drug
Disease control CompletedParkinson's disease is a common condition particularly affecting older people. Falls are a very frequent complication of the disease affecting 60% of people with Parkinson's every year. As the population ages, the number of people living with Parkinson's disease and the occurrenc…
Phase: PHASE3 • Sponsor: University of Bristol • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Blood test could spot returning colon cancer months before scans
Knowledge-focused OngoingIMPROVE-IT2 is a randomized multicenter trial comparing the outcomes of ctDNA guided post-operative surveillance and standard-of-care CT-scan surveillance. The hypothesis of this study is that ctDNA guided post-operative surveillance combining ctDNA and radiological assessments c…
Phase: NA • Sponsor: Claus Lindbjerg Andersen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
AI reads endoscopy images to spot dangerous esophageal tumors
Diagnosis OngoingThe goal of this retrospective observational study is to evaluate whether preoperative endoscopic imaging can accurately assess tumor invasion depth in patients with early esophageal neoplasia undergoing endoscopic submucosal dissection (ESD). The main question it aims to answer…
Sponsor: Fudan University • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Artificial intelligence could help guide liver cancer treatment after surgery
Knowledge-focused CompletedThis is a completed multi-center retrospective observational study focusing on patients who received curative surgical resection for hepatocellular carcinoma (HCC). We collected anonymized historical clinical data, preoperative gadoxetic acid-enhanced MRI scans and digital pathol…
Sponsor: Anhui Provincial Hospital • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Simple blood test could spot deadly bile duct cancers earlier
Diagnosis Recruiting nowBiliary tract carcinoma (BTC), including gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma, ranks sixth in incidence among gastrointestinal malignancies and tenth in cancer-related mortality worldwide. Due to the lack of specific early sympt…
Sponsor: Yingbin Liu, MD, PhD, FACS • Aim: Diagnosis
Last updated Jun 26, 2026 18:38 UTC
-
New online program aims to lift the cloud of depression for new mothers
Symptom relief Recruiting nowIMPRINT strengthens maternal and child health by screening, treating and preventing maternal perinatal depression, the most common complication of pregnancy and the child's first 1000 days. It is associated with poor pregnancy outcome and perinatal mortality and has adverse conse…
Phase: NA • Sponsor: Katri Räikkönen • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Could your own fat cells help heal a traumatic brain injury?
Disease control CompletedThis study aims to determine the safety of HB-adMSC infusion and treatment effects of HB-adMSC infusion on brain structure, neurocognitive/functional outcomes, and neuroinflammation after subacute and chronic neurological injury in adults.
Phase: PHASE1, PHASE2 • Sponsor: Hope Biosciences LLC • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Immunotherapy after surgery may keep melanoma from coming back
Disease control OngoingSubjects with resectable melanoma will receive neoadjuvant nivolumab followed by surgical resection. Post-operatively, subjects will receive open-label treatment with up to 1 year of adjuvant nivolumab or ipilimumab plus nivolumab as determined by pathologic response at the time …
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Stool transplant plus antibody drug shows promise against recurrent c. diff in IBD patients
Prevention CompletedThis is a randomized controlled trial to assess the clinical and microbiological impacts of FMT in combination with Bezlotoxumab (bezlo) compared to FMT in combination with placebo in patients with both inflammatory bowel disease (IBD) a and clostridium difficile infection (CDI).…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
New cocktail therapy takes on tough lymphoma
Disease control Recruiting nowAim of this study will evaluate the Efficacy and Safety of Anti-PD-1 monoclonal antibody Combined Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma Patients.
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
AI-powered PET scans may predict prostate cancer aggressiveness before surgery
Knowledge-focused CompletedThis single-center retrospective study aims to develop an interpretable radiomics model based on dual-tracer PET/CT to preoperatively predict the postoperative pathological Gleason grade group in treatment-naïve prostate cancer patients. A machine learning-based three-class predi…
Sponsor: Xiangya Hospital of Central South University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
AI reads CT scans to predict stomach Cancer's return
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to develop a model for predicting postoperative recurrence in patients with LAGC using artificial intelligence (AI) technology based on preoperative computed tomography (CT) images
Sponsor: Liu Yang • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Designer immune cells take on rare sarcomas
Disease control OngoingThis trial will evaluate safety and efficacy of human engineered T-cell therapies, in participants with advanced tumors. This trial is a sub study of the Master study NCT03967223.
Phase: PHASE2 • Sponsor: USWM, LLC (dba US WorldMeds) • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Supercharged immune cells take on Hard-to-Treat cancers
Disease control OngoingThis trial will evaluate safety and efficacy of human engineered T-cell therapies, in participants with advanced tumors.
Phase: PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC